Dai, Xiaomeng <br/><br/>
Targeting CAMKII to reprogram tumor-associated macrophages and inhibit tumor cells for cancer immunotherapy with an injectable hybrid peptide hydrogel.  [electronic resource] 

 -  Theranostics  2020 
 - 3049-3063 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1838-7640 
<br/><br/><label>Standard No.: </label>10.7150/thno.42385  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Ascites--etiology<br/>B7-H1 Antigen--biosynthesis<br/>Benzylamines--administration & dosage<br/>Calcium-Calmodulin-Dependent Protein Kinase Type 2--antagonists & inhibitors<br/>Cellular Reprogramming Techniques<br/>Drug Compounding<br/>Drug Screening Assays, Antitumor<br/>Female<br/>Hydrogels--administration & dosage<br/>Immunotherapy--methods<br/>Injections, Intraperitoneal<br/>Liver Neoplasms, Experimental--complications<br/>Macrophage Activation<br/>Male<br/>Melanoma, Experimental--immunology<br/>Melitten--administration & dosage<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Molecular Targeted Therapy--methods<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Oligopeptides--administration & dosage<br/>Protein Kinase Inhibitors--administration & dosage<br/>Random Allocation<br/>Recombinant Fusion Proteins--administration & dosage<br/>Sulfonamides--administration & dosage<br/>Tumor Escape--drug effects<br/>Tumor-Associated Macrophages--classification